Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 13, 2019 09:00 ET | Source: Auris Medical AG

Auris Medical Receives FDA and EMA Guidance for Keyzilen® Late-Stage Clinical Development Program

Hamilton, Bermuda, Sept. 13, 2019 (GLOBE NEWSWIRE) -- Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical...
August 26, 2019 09:00 ET | Source: Auris Medical AG

Auris Medical Announces Formation of Scientific Advisory Board for Tinnitus Programs

Hamilton, Bermuda, Aug. 26, 2019 (GLOBE NEWSWIRE) -- Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical...